US Study Tests Psilocybin to Prevent Chemotherapy Nerve Damage

A study published in the journal Science suggests psilocybin may prevent peripheral neuropathy, a nerve-damaging side effect that affects 75% of chemotherapy patients.

Researchers found that two doses of psilocybin in rodents protected nerve cells and mitochondrial transport without hindering the drug's cancer-fighting efficacy.

The MD Anderson Cancer Center plans to launch clinical trials later this year, though experts warn patients against self-administering the drug due to potential psychological risks.